Results 31 to 40 of about 54,568 (249)

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus [PDF]

open access: yes, 2015
Introduction ES-62, a phosphorylcholine (PC)-containing immunomodulator secreted by the parasitic worm Acanthocheilonema viteae, protects against nephritis in the MRL/Lpr mouse model of systemic lupus erythematosus (SLE).
Harnett, M. M.   +4 more
core   +1 more source

Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease

open access: yesBMC Rheumatology, 2023
Background Antinuclear antibodies (ANA) are antibodies present in several autoimmune disorders. However, a large proportion of the general population (20%) also have a positive test; very few of these individuals will develop an autoimmune disease, and ...
Jacy T. Zanussi   +8 more
doaj   +1 more source

Autoimmune diseases and their manifestations on oral cavity: diagnosis and clinical management [PDF]

open access: yes, 2018
Oral signs are frequently the first manifestation of autoimmune diseases. For this reason, dentists play an important role in the detection of emerging autoimmune pathologies.
Bossù, Maurizio   +5 more
core   +2 more sources

Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited

open access: yesDiagnostic Pathology, 2009
It has been more than 50 years since antinuclear antibodies were first discovered and found to be associated with connective tissue diseases. Since then different methods have been described and used for their detection or confirmation.
Minz Ranjana   +2 more
doaj   +1 more source

Immunology markers that can be predictive for the diagnosis of juvenile idiopathic arthritis

open access: yesJournal of Laboratory Medicine, 2020
This study aimed to investigate the implications of antinuclear antibodies (ANAs) in juvenile idiopathic arthritis (JIA), the association with uveitis and the favorable evolution of the disease.
Sur Lucia M.   +9 more
doaj   +1 more source

Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis [PDF]

open access: yes, 2009
Introduction Chemokines and their receptors control immune cell migration during infections as well as in autoimmune responses. A 32 bp deletion in the gene of the chemokine receptor CCR5 confers protection against HIV infection, but has also been ...
Arnold, Sybille   +6 more
core   +2 more sources

Autoantibody profiles and their association with blood eosinophils in asthma and COPD

open access: yesAllergology International, 2017
Background: Autoimmune involvement in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD) has been proposed, and autoantibodies are a hallmark of autoimmunity.
Koji Tamai   +10 more
doaj   +1 more source

Antinuclear antibody profiling in uveitis [PDF]

open access: yesActa Ophthalmologica, 2018
_Editor,_ Antinuclear antibodies (ANA) are antibodies directed against a variety of nuclear antigens and are detected in patients with autoimmune diseases. Antinuclear antibodies (ANA) profiling is relevant for diagnostic purposes in various diseases, including systemic lupus erythematosus (SLE), Sj€ogren syndrome and systemic sclerosis (Smeenk et ...
Josianne C. ten Berge   +3 more
openaire   +4 more sources

Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database. [PDF]

open access: yes, 2017
Racial differences exist in the severity of systemic sclerosis (SSc). To enhance our knowledge about SSc in African Americans, we established a comprehensive clinical database from the largest multicenter cohort of African American SSc patients assembled
Boin, Francesco   +28 more
core   +1 more source

Antinuclear antibodies in systemic sclerosis associated with increased risk of malignancy

open access: yesPrzegląd Dermatologiczny, 2018
Patients with systemic sclerosis are at 1.5–5-fold increased risk of developing malignant diseases. It has been shown that some types of antinuclear antibodies associated with systemic sclerosis may have predictive value for development of malignant ...
Anna Stochmal   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy